$SINT

AMEDICA Corp

CIK:0001269026|SEC Filings

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Total revenue	$ 452	$ 151	$ 832	$ 520
Costs of revenue	174	94	410	340
Gross profit	278	57	422	180
Operating expenses:
Research and development	573	1,238	937	2,354
General and administrative	2,318	1,415	4,853	2,734
Sales and marketing	273	21	672	41
Grant and contract expenses	2	48	55	99
Total operating expenses	3,166	2,722	6,517	5,228
Loss from operations	(2,888)	(2,665)	(6,095)	(5,048)
Other income (expenses):
Interest expense	(2)	(14)	(14)	(27)
Interest income	12	46	34	87
Gain on disposal of equipment		352		327
Change in fair value of derivative liabilities	139	(39)	482	48
Other income, net	33	2	66	3
Total other income, net	182	347	568	438
Net loss before income taxes	(2,706)	(2,318)	(5,527)	(4,610)
Provision for income taxes
Net loss	(2,706)	(2,318)	(5,527)	(4,610)
Deemed dividend – warrant modification	(926)		(926)
Net loss attributable to common stockholders	$ (3,632)	$ (2,318)	$ (6,453)	$ (4,610)
Net loss per share – basic and diluted
Basic – net loss	$ (0.56)	$ (0.91)	$ (1.25)	$ (2.14)
Basic – deemed dividend – warrant modification	(0.19)		(0.21)
Basic – attributable to common stockholders	(0.75)	(0.91)	(1.46)	(2.14)
Diluted – net loss	(0.56)	(0.91)	(1.25)	(2.14)
Diluted – deemed dividend – warrant modification	(0.19)		(0.21)
Diluted – attributable to common stockholders	$ (0.75)	$ (0.91)	$ (1.46)	$ (2.14)
Weighted average common shares outstanding:
Basic	4,849,080	2,535,120	4,433,861	2,156,032
Diluted	4,849,570	2,535,120	4,434,615	2,156,223
Product [Member]
Total revenue	$ 447	$ 100	$ 747	$ 391
Grant and Contract [Member]
Total revenue	$ 5	$ 51	$ 85	$ 129

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities
Net loss	$ (5,527)	$ (4,610)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	132	171
Impairment of Armor		64
Amortization of right of use asset	161	169
Loss on disposal of subsidiary		25
Amortization of intangible assets	17	3
Stock based compensation - Employee	847	193
Stock based compensation - Non-employee	36	264
Change in fair value of derivative liabilities	(482)	(48)
Bad debt (recoveries) expense	9	(3)
Gain on disposal of equipment		(352)
Changes in operating assets and liabilities:
Trade accounts receivable	(160)	12
Prepaid expenses and other current assets	(176)	(130)
Inventories	(1,207)	153
Accounts payable and accrued liabilities	1,285	(217)
Other liabilities		784
Payments on operating lease liability	(193)	(188)
Net cash used in operating activities	(5,258)	(3,710)
Cash flows from investing activities
Purchase of property and equipment	(91)	(59)
Proceeds from sale of property and equipment		352
Disposal of property and equipment, net of cash received		(4)
Net cash provided by (used in) investing activities	(91)	289
Cash flows from financing activities
Proceeds from issuance of common stock in connection with ATM, net of fees	811
Proceeds from issuance of common stock and warrants, net of cash fees	4,049	4,379
Purchase of common stock into treasury		(133)
Payments on debt	(61)	(103)
Net cash provided by financing activities	4,799	4,143
Net increase (decrease) in cash and cash equivalents	(550)	722
Cash and cash equivalents at beginning of period	4,140	3,598
Cash and cash equivalents at end of period	3,590	4,320
Noncash investing and financing activities
Debt issued for prepaid insurance	156	180
Issuance of common stock and prefunded warrants related to warrant modification	1,685
Deemed dividend related to warrant modification	926
Supplemental cash flow information
Cash paid for interest	$ 14	$ 27

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 3,590,000	$ 4,140,000
Accounts and other receivables, net of allowance for credit losses of $11.0 and $2.4 respectively	329,000	178,000
Prepaid expenses and other current assets	854,000	507,000
Inventories	2,252,000	825,000
Total current assets	7,025,000	5,650,000
Inventories		219,000
Property and equipment, net	434,000	476,000
Intangible assets, net	125,000	142,000
Goodwill	302,000	302,000
Operating lease right of use asset	2,297,000	2,458,000
Other long-term assets	247,000	259,000
Total assets	10,430,000	9,506,000
Current liabilities:
Accounts payable	934,000	382,000
Accrued liabilities	1,157,000	422,000
Debt	102,000	7,000
Derivative liabilities	345,000	827,000
Current portion of operating lease liability	426,000	398,000
Other current liabilities	13,000	1,697,000
Total current liabilities	2,977,000	3,733,000
Operating lease liability, net of current portion	2,623,000	2,844,000
Total liabilities	5,600,000	6,577,000
Commitments and contingencies
Common stock, $0.01 par value, 250,000,000 shares authorized; 6,663,489 and 4,021,293 shares issued and 6,613,065 and 3,970,869 outstanding as of June 30, 2026 and December 31, 2025, respectively.	67,000	40,000
Treasury Stock, 50,424 shares as of June 30, 2026 and December 31, 2025.	(133,000)	(133,000)
Additional paid-in capital	302,525,000	295,124,000
Accumulated deficit	(297,629,000)	(292,102,000)
Total stockholders’ equity	4,830,000	2,929,000
Total liabilities and stockholders’ equity	10,430,000	9,506,000
Series B Convertible Preferred Stock [Member]
Current liabilities:
Convertible preferred stock, value
Series C Convertible Preferred Stock [Member]
Current liabilities:
Convertible preferred stock, value
Series D Convertible Preferred Stock [Member]
Current liabilities:
Convertible preferred stock, value